{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:47:09Z","timestamp":1787683629835,"version":"build-2784847793"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100011102","name":"European Union Seventh Framework Programme","doi-asserted-by":"crossref","award":["EC-GA No. 305266"],"award-info":[{"award-number":["EC-GA No. 305266"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CRC656","award":["A09"],"award-info":[{"award-number":["A09"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13075-016-1121-z","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T13:00:28Z","timestamp":1477314028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["S100A8\/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis"],"prefix":"10.1186","volume":"18","author":[{"given":"Edwin J. W.","family":"Geven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn H. J.","family":"van den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Di Ceglie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Ascone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahla","family":"Abdollahi-Roodsaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annet W.","family":"Sloetjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sch\u00e4fers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fons A. J.","family":"van de Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"van der Kraan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije I.","family":"Koenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Foell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vogl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L. E. M.","family":"van Lent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,24]]},"reference":[{"key":"1121_CR1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-4615-4857-7_9","volume":"455","author":"BB Varbanova","year":"1999","unstructured":"Varbanova BB, Baleva M, Nikolov K, Mihailova D. Prevalence of IgM-, IgA- and IgG-rheumatoid factors in seronegative polyarticular disease compared to pauciarticular disease in juvenile chronic arthritis as measured by ELISA. Adv Exp Med Biol. 1999;455:61\u20138.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"1121_CR2","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390\u20132.","journal-title":"J Rheumatol"},{"issue":"8","key":"1121_CR3","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, Group CS. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665\u201373.","journal-title":"Arthritis Rheum"},{"issue":"4 Suppl 55","key":"1121_CR4","first-page":"S3","volume":"27","author":"TG Benedek","year":"2009","unstructured":"Benedek TG. How did ankylosing spondylitis become a separate disease? Clin Exp Rheumatol. 2009;27(4 Suppl 55):S3\u20139.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"1121_CR5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/BOR.0000000000000098","volume":"26","author":"N Nirmala","year":"2014","unstructured":"Nirmala N, Grom A, Gram H. Biomarkers in systemic juvenile idiopathic arthritis: a comparison with biomarkers in cryopyrin-associated periodic syndromes. Curr Opin Rheumatol. 2014;26(5):543\u201352.","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"1121_CR6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11926-014-0453-4","volume":"16","author":"V Chandran","year":"2014","unstructured":"Chandran V, Scher JU. Biomarkers in psoriatic arthritis: recent progress. Curr Rheumatol Rep. 2014;16(11):453.","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"1121_CR7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.autrev.2016.02.002","volume":"16","author":"K Prajzlerova","year":"2016","unstructured":"Prajzlerova K, Grobelna K, Pavelka K, Senolt L, Filkova M. An update on biomarkers in axial spondyloarthritis. Autoimmun Rev. 2016;16(5):501\u20139.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"1121_CR8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3899\/jrheum.140628","volume":"42","author":"M Abildtrup","year":"2015","unstructured":"Abildtrup M, Kingsley GH, Scott DL. Calprotectin as a biomarker for rheumatoid arthritis: a systematic review. J Rheumatol. 2015;42(5):760\u201370.","journal-title":"J Rheumatol"},{"issue":"7","key":"1121_CR9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/annrheumdis-2015-208025","volume":"75","author":"H Cypers","year":"2015","unstructured":"Cypers H, Varkas G, Beeckman S, Debusschere K, Vogl T, Roth J, Drennan MB, Lavric M, Foell D, Cuvelier CA, et al. Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis. Ann Rheum Dis. 2015;75(7):1357\u201362.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1121_CR10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s13075-014-0413-4","volume":"16","author":"MC Turina","year":"2014","unstructured":"Turina MC, Yeremenko N, Paramarta JE, De Rycke L, Baeten D. Calprotectin (S100A8\/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis. Arthritis Res Ther. 2014;16(4):413.","journal-title":"Arthritis Res Ther"},{"key":"1121_CR11","doi-asserted-by":"crossref","first-page":"696415","DOI":"10.1155\/2014\/696415","volume":"2014","author":"C Hansson","year":"2014","unstructured":"Hansson C, Eriksson C, Alenius GM. S-calprotectin (S100A8\/S100A9): a potential marker of inflammation in patients with psoriatic arthritis. J Immunol Res. 2014;2014:696415.","journal-title":"J Immunol Res"},{"issue":"12","key":"1121_CR12","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1136\/annrheumdis-2012-201329","volume":"71","author":"J Gerss","year":"2012","unstructured":"Gerss J, Roth J, Holzinger D, Ruperto N, Wittkowski H, Frosch M, Wulffraat N, Wedderburn L, Stanevicha V, Mihaylova D, et al. Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study. Ann Rheum Dis. 2012;71(12):1991\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1121_CR13","doi-asserted-by":"crossref","unstructured":"Pruenster M, Vogl T, Roth J, Sperandio M. S100A8\/A9: from basic science to clinical application. Pharmacol Ther. 2016. doi:10.1016\/j.pharmthera.2016.07.015","DOI":"10.1016\/j.pharmthera.2016.07.015"},{"issue":"6","key":"1121_CR14","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.celrep.2014.11.020","volume":"9","author":"J Austermann","year":"2014","unstructured":"Austermann J, Friesenhagen J, Fassl SK, Petersen B, Ortkras T, Burgmann J, Barczyk-Kahlert K, Faist E, Zedler S, Pirr S, et al. Alarmins MRP8 and MRP14 induce stress tolerance in phagocytes under sterile inflammatory conditions. Cell Rep. 2014;9(6):2112\u201323.","journal-title":"Cell Rep"},{"issue":"2","key":"1121_CR15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4049\/jimmunol.1401085","volume":"194","author":"SK Fassl","year":"2015","unstructured":"Fassl SK, Austermann J, Papantonopoulou O, Riemenschneider M, Xue J, Bertheloot D, Freise N, Spiekermann C, Witten A, Viemann D, et al. Transcriptome assessment reveals a dominant role for TLR4 in the activation of human monocytes by the alarmin MRP8. J Immunol. 2015;194(2):575\u201383.","journal-title":"J Immunol"},{"issue":"7","key":"1121_CR16","doi-asserted-by":"crossref","first-page":"e68694","DOI":"10.1371\/journal.pone.0068694","volume":"8","author":"MT Kuipers","year":"2013","unstructured":"Kuipers MT, Vogl T, Aslami H, Jongsma G, van den Berg E, Vlaar AP, Roelofs JJ, Juffermans NP, Schultz MJ, van der Poll T, et al. High levels of S100A8\/A9 proteins aggravate ventilator-induced lung injury via TLR4 signaling. PLoS One. 2013;8(7):e68694.","journal-title":"PLoS One"},{"issue":"2","key":"1121_CR17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2567.2012.03619.x","volume":"137","author":"M Riva","year":"2012","unstructured":"Riva M, Kallberg E, Bjork P, Hancz D, Vogl T, Roth J, Ivars F, Leanderson T. Induction of nuclear factor-kappaB responses by the S100A9 protein is Toll-like receptor-4-dependent. Immunology. 2012;137(2):172\u201382.","journal-title":"Immunology"},{"issue":"9","key":"1121_CR18","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/nm1638","volume":"13","author":"T Vogl","year":"2007","unstructured":"Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll T, Sorg C, et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med. 2007;13(9):1042\u20139.","journal-title":"Nat Med"},{"issue":"5","key":"1121_CR19","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/art.33495","volume":"64","author":"RF Schelbergen","year":"2012","unstructured":"Schelbergen RF, Blom AB, van den Bosch MH, Sloetjes A, Abdollahi-Roodsaz S, Schreurs BW, Mort JS, Vogl T, Roth J, van den Berg WB, et al. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4. Arthritis Rheum. 2012;64(5):1477\u201387.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1121_CR20","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1002\/art.24074","volume":"58","author":"PL Lent van","year":"2008","unstructured":"van Lent PL, Grevers LC, Blom AB, Arntz OJ, van de Loo FA, van der Kraan P, Abdollahi-Roodsaz S, Srikrishna G, Freeze H, Sloetjes A, et al. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis. Arthritis Rheum. 2008;58(12):3776\u201387.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1121_CR21","doi-asserted-by":"crossref","first-page":"R16","DOI":"10.1186\/ar2917","volume":"12","author":"H Zreiqat","year":"2010","unstructured":"Zreiqat H, Belluoccio D, Smith MM, Wilson R, Rowley LA, Jones K, Ramaswamy Y, Vogl T, Roth J, Bateman JF, et al. S100A8 and S100A9 in experimental osteoarthritis. Arthritis Res Ther. 2010;12(1):R16.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"1121_CR22","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1136\/ard.2007.077800","volume":"67","author":"PL Lent van","year":"2008","unstructured":"van Lent PL, Grevers L, Blom AB, Sloetjes A, Mort JS, Vogl T, Nacken W, van den Berg WB, Roth J. Myeloid-related proteins S100A8\/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann Rheum Dis. 2008;67(12):1750\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1121_CR23","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1038\/ncomms5593","volume":"5","author":"T Vogl","year":"2014","unstructured":"Vogl T, Eisenblatter M, Voller T, Zenker S, Hermann S, van Lent P, Faust A, Geyer C, Petersen B, Roebrock K, et al. Alarmin S100A8\/S100A9 as a biomarker for molecular imaging of local inflammatory activity. Nat Commun. 2014;5:4593.","journal-title":"Nat Commun"},{"issue":"8","key":"1121_CR24","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/ard.2006.064741","volume":"66","author":"HB Hammer","year":"2007","unstructured":"Hammer HB, Odegard S, Fagerhol MK, Landewe R, van der Heijde D, Uhlig T, Mowinckel P, Kvien TK. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis. Ann Rheum Dis. 2007;66(8):1093\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1121_CR25","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/annrheumdis-2014-205506","volume":"73","author":"MC Turina","year":"2014","unstructured":"Turina MC, Sieper J, Yeremenko N, Conrad K, Haibel H, Rudwaleit M, Baeten D, Poddubnyy D. Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis. Ann Rheum Dis. 2014;73(9):1746\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1121_CR26","first-page":"2089","volume":"34","author":"TM Madland","year":"2007","unstructured":"Madland TM, Larsen A, Brun JG. S100 proteins calprotectin and S100A12 are related to radiographic changes rather than disease activity in psoriatic arthritis with low disease activity. J Rheumatol. 2007;34(10):2089\u201392.","journal-title":"J Rheumatol"},{"issue":"2","key":"1121_CR27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.191.2.313","volume":"191","author":"R Horai","year":"2000","unstructured":"Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, Ikuse T, Asano M, Iwakura Y. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med. 2000;191(2):313\u201320.","journal-title":"J Exp Med"},{"issue":"10","key":"1121_CR28","first-page":"643","volume":"16","author":"P Sarzi-Puttini","year":"2014","unstructured":"Sarzi-Puttini P, Atzeni F. New biological treatments for psoriatic arthritis. Isr Med Assoc J. 2014;16(10):643\u20135.","journal-title":"Isr Med Assoc J"},{"issue":"6","key":"1121_CR29","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/annrheumdis-2011-200439","volume":"71","author":"D Monnet","year":"2012","unstructured":"Monnet D, Kadi A, Izac B, Lebrun N, Letourneur F, Zinovieva E, Said-Nahal R, Chiocchia G, Breban M. Association between the IL-1 family gene cluster and spondyloarthritis. Ann Rheum Dis. 2012;71(6):885\u201390.","journal-title":"Ann Rheum Dis"},{"issue":"1-2","key":"1121_CR30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/pr.2013.187","volume":"75","author":"CK Correll","year":"2014","unstructured":"Correll CK, Binstadt BA. Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis. Pediatr Res. 2014;75(1-2):176\u201383.","journal-title":"Pediatr Res"},{"issue":"2","key":"1121_CR31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.191.2.303","volume":"191","author":"MJ Nicklin","year":"2000","unstructured":"Nicklin MJ, Hughes DE, Barton JL, Ure JM, Duff GW. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med. 2000;191(2):303\u201312.","journal-title":"J Exp Med"},{"issue":"1","key":"1121_CR32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1172\/JCI32639","volume":"118","author":"S Abdollahi-Roodsaz","year":"2008","unstructured":"Abdollahi-Roodsaz S, Joosten LA, Koenders MI, Devesa I, Roelofs MF, Radstake TR, Heuvelmans-Jacobs M, Akira S, Nicklin MJ, Ribeiro-Dias F, et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest. 2008;118(1):205\u201316.","journal-title":"J Clin Invest"},{"issue":"1","key":"1121_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cmmi.1486","volume":"8","author":"B Waschkau","year":"2013","unstructured":"Waschkau B, Faust A, Schafers M, Bremer C. Performance of a new fluorescence-labeled MMP inhibitor to image tumor MMP activity in vivo in comparison to an MMP-activatable probe. Contrast Media Mol Imaging. 2013;8(1):1\u201311.","journal-title":"Contrast Media Mol Imaging"},{"issue":"3","key":"1121_CR34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.0022-202X.2004.22305.x","volume":"122","author":"J Shepherd","year":"2004","unstructured":"Shepherd J, Little MC, Nicklin MJ. Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist. J Invest Dermatol. 2004;122(3):665\u20139.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"1121_CR35","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/ATVBAHA.109.201749","volume":"30","author":"K Isoda","year":"2010","unstructured":"Isoda K, Matsuki T, Kondo H, Iwakura Y, Ohsuzu F. Deficiency of interleukin-1 receptor antagonist induces aortic valve disease in BALB\/c mice. Arterioscler Thromb Vasc Biol. 2010;30(4):708\u201315.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"1121_CR36","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrrheum.2015.79","volume":"11","author":"D Holzinger","year":"2015","unstructured":"Holzinger D, Kessel C, Omenetti A, Gattorno M. From bench to bedside and back again: translational research in autoinflammation. Nat Rev Rheumatol. 2015;11(10):573\u201385.","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"1121_CR37","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","volume":"201","author":"V Pascual","year":"2005","unstructured":"Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med. 2005;201(9):1479\u201386.","journal-title":"J Exp Med"},{"issue":"9","key":"1121_CR38","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/CIRCULATIONAHA.105.564658","volume":"112","author":"T Matsuki","year":"2005","unstructured":"Matsuki T, Isoda K, Horai R, Nakajima A, Aizawa Y, Suzuki K, Ohsuzu F, Iwakura Y. Involvement of tumor necrosis factor-alpha in the development of T cell-dependent aortitis in interleukin-1 receptor antagonist-deficient mice. Circulation. 2005;112(9):1323\u201331.","journal-title":"Circulation"},{"issue":"5","key":"1121_CR39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/MCO.0b013e32833cf3bc","volume":"13","author":"X Zhou","year":"2010","unstructured":"Zhou X, Fragala MS, McElhaney JE, Kuchel GA. Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research. Curr Opin Clin Nutr Metab Care. 2010;13(5):541\u20137.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"4","key":"1121_CR40","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11926-010-0107-0","volume":"12","author":"V Chandran","year":"2010","unstructured":"Chandran V, Gladman DD. Update on biomarkers in psoriatic arthritis. Curr Rheumatol Rep. 2010;12(4):288\u201394.","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"1121_CR41","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s10067-015-2949-3","volume":"34","author":"JD Reveille","year":"2015","unstructured":"Reveille JD. Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. Clin Rheumatol. 2015;34(6):1009\u201318.","journal-title":"Clin Rheumatol"},{"key":"1121_CR42","doi-asserted-by":"crossref","first-page":"h5079","DOI":"10.1136\/bmj.h5079","volume":"351","author":"C Mohan","year":"2015","unstructured":"Mohan C, Assassi S. Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity? BMJ. 2015;351:h5079.","journal-title":"BMJ"},{"issue":"4","key":"1121_CR43","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/BOR.0000000000000180","volume":"27","author":"WP Maksymowych","year":"2015","unstructured":"Maksymowych WP. Biomarkers in axial spondyloarthritis. Curr Opin Rheumatol. 2015;27(4):343\u20138.","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"1121_CR44","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/pr.2015.144","volume":"78","author":"S Shenoi","year":"2015","unstructured":"Shenoi S, Ou JN, Ni C, Macaubas C, Gersuk VH, Wallace CA, Mellins ED, Stevens AM. Comparison of biomarkers for systemic juvenile idiopathic arthritis. Pediatr Res. 2015;78(5):554\u20139.","journal-title":"Pediatr Res"},{"issue":"11","key":"1121_CR45","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.bbamcr.2006.08.028","volume":"1763","author":"T Vogl","year":"2006","unstructured":"Vogl T, Leukert N, Barczyk K, Strupat K, Roth J. Biophysical characterization of S100A8 and S100A9 in the absence and presence of bivalent cations. Biochim Biophys Acta. 2006;1763(11):1298\u2013306.","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"1121_CR46","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/rheumatology\/ket152","volume":"52","author":"H Moncrieffe","year":"2013","unstructured":"Moncrieffe H, Ursu S, Holzinger D, Patrick F, Kassoumeri L, Wade A, Roth J, Wedderburn LR. A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8\/14 protein. Rheumatology (Oxford). 2013;52(8):1467\u201376.","journal-title":"Rheumatology (Oxford)"},{"key":"1121_CR47","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13075-015-0723-1","volume":"17","author":"J Anink","year":"2015","unstructured":"Anink J, Van Suijlekom-Smit LW, Otten MH, Prince FH, van Rossum MA, Dolman KM, Hoppenreijs EP, ten Cate R, Ursu S, Wedderburn LR, et al. MRP8\/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis. Arthritis Res Ther. 2015;17:200.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"1121_CR48","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/acr.22248","volume":"66","author":"F Rothmund","year":"2014","unstructured":"Rothmund F, Gerss J, Ruperto N, Dabritz J, Wittkowski H, Frosch M, Wulffraat NM, Wedderburn LR, Holzinger D, Gohar F, et al. Validation of relapse risk biomarkers for routine use in patients with juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2014;66(6):949\u201355.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"1121_CR49","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/art.30290","volume":"63","author":"LC Grevers","year":"2011","unstructured":"Grevers LC, de Vries TJ, Vogl T, Abdollahi-Roodsaz S, Sloetjes AW, Leenen PJ, Roth J, Everts V, van den Berg WB, van Lent PL. S100A8 enhances osteoclastic bone resorption in vitro through activation of Toll-like receptor 4: implications for bone destruction in murine antigen-induced arthritis. Arthritis Rheum. 2011;63(5):1365\u201375.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-1121-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T08:05:34Z","timestamp":1589702734000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-016-1121-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,24]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1121"],"URL":"https:\/\/doi.org\/10.1186\/s13075-016-1121-z","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,24]]},"article-number":"247"}}